$AMC

Opendoor stock surged from under $1 to $10.87 in 2025, then fell to $5.46 amid skepticism about sustainability amid housing market headwinds and continued analyst losses expectations.

AMC refinances costly debt into 2031 term loan amid box office recovery. High short interest creates squeeze potential, though sustained gains require margin expansion and free cash flow evidence.

AMC trades at 2x peer valuations despite debt burden. Stock needs operational improvement and significant repricing before becoming attractive to investors.

Class action lawsuit filed against AMC Entertainment over alleged materially false statements regarding APE preferred equity units and distribution rights following August 2023 conversion.

AMC faces class action lawsuit alleging securities fraud over APE unit dividend exclusion, potentially affecting investors who purchased units between August 2022 and November 2023.

Pomerantz Law Firm files class action suit against $RGNX after FDA clinical hold on gene therapy candidates triggers 17.9% stock collapse. Investor deadline: April 14, 2026.

Pomerantz Law Firm filed class action suit against $AMC over alleged securities fraud involving APE preferred equity holders excluded from special dividend. Investors must act by April 20, 2026.

Box office strength signals resilient consumer spending. The Super Mario Galaxy Movie's $195M Easter weekend haul and record 2026 ticket sales boosted AMC 11%, suggesting discretionary spending remains intact despite inflation.

Pomerantz Law Firm filed class action against $AMC over alleged securities fraud regarding APE preferred equity units excluded from special dividend. Investors must act by April 20, 2026.

Pomerantz Law Firm filed class action against $QURE after 49% stock decline following FDA concerns over gene therapy study data adequacy.

PomDoctor stock plummeted 91% to $0.50 from $6.09 amid pump-and-dump fraud allegations. Pomerantz Law Firm filed class action; investors have until April 6, 2026 to claim losses.

Kyndryl Holdings faces 55% stock collapse after SEC financial reporting investigation and executive departures. Class action lawsuit filed; deadline April 13, 2026.

AMC Entertainment jumped 12% following record Easter weekend revenue, with analysts projecting 80%+ upside and short squeeze potential amid consumer spending strength.

Class action lawsuit filed against AMC Entertainment over APE dividend exclusion, alleging securities fraud and material misrepresentations regarding investor protections.

Class action filed against $AMC over alleged securities violations regarding APE preferred equity units. Investors claim misleading disclosures about distribution rights after conversion.

Class action lawsuit filed against $AMC alleging securities fraud over APE preferred equity units excluded from special dividend after conversion to common stock.

Domestic box office jumps 20% year-over-year, positioning Cinemark, IMAX, and EPR Properties to benefit from theater sector revival.

Class action lawsuit filed against AMC Entertainment over alleged securities violations related to APE preferred equity units. Investors claim material misstatements about distribution rights.

Class action lawsuit filed against $AMC alleging securities fraud over APE preferred equity units and undisclosed dividend exclusion loophole.

Class action filed against $AMC alleging securities fraud over APE preferred equity units being excluded from special dividend after conversion to common stock.